Literature DB >> 16546008

Drug interactions and smoking: raising awareness for acute and critical care providers.

Lisa A Kroon1.   

Abstract

Because the prevalence of smoking in the United States remains significantly high, it is important to determine a patient's smoking status and perform a complete medication history to assess for potential drug interactions with smoking. Tobacco smoke can increase the hepatic metabolism and can oppose the pharmacologic effects of certain drugs. This article reviews the clinically significant drug interactions, resulting primarily from the induction of cytochrome P450 enzymes by tobacco smoke, of which all acute and critical care providers need to be aware when making therapeutic decisions and recommendations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546008     DOI: 10.1016/j.ccell.2005.11.007

Source DB:  PubMed          Journal:  Crit Care Nurs Clin North Am        ISSN: 0899-5885            Impact factor:   1.326


  4 in total

1.  Caffeine intake, smoking, and risk of Parkinson disease in men and women.

Authors:  Rui Liu; Xuguang Guo; Yikyung Park; Xuemei Huang; Rashmi Sinha; Neal D Freedman; Albert R Hollenbeck; Aaron Blair; Honglei Chen
Journal:  Am J Epidemiol       Date:  2012-04-13       Impact factor: 4.897

Review 2.  Drugs and Diseases Interacting with Cigarette Smoking in US Prescription Drug Labelling.

Authors:  Haibo Li; Qiang Shi
Journal:  Clin Pharmacokinet       Date:  2015-05       Impact factor: 6.447

Review 3.  Therapeutic drug monitoring in a developing nation: a clinical guide.

Authors:  Ndubuisi Nwobodo
Journal:  JRSM Open       Date:  2014-07-08

4.  In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects.

Authors:  Yan Li; Liangang Liu; Xiaomin Wang; Chengyue Zhang; Josephine Reyes; Matthew Hoffmann; Maria Palmisano; Simon Zhou
Journal:  J Clin Pharmacol       Date:  2018-05-15       Impact factor: 3.126

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.